Indivior Proposes New Corporate Structure To Achieve U.S. Domiciliation
I'm PortAI, I can summarize articles.
Indivior PLC has proposed a new corporate structure to change its domicile from the U.K. to the U.S. Shareholders will receive one share of Indivior Pharmaceuticals, Inc. (IPI) for each PLC share, with no additional equity raised. Indivior PLC will become a wholly owned subsidiary of IPI, which will be listed on NASDAQ under the symbol INDV. The scheme is expected to be effective by January 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments